# Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability

> **NCT01241942** · NA · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 11 (actual)

## Conditions studied

- Emphysema
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Pulmonary Fibrosis
- Bronchiectasis
- Sarcoidosis
- Pulmonary Hypertension
- Alpha-1 Antitrypsin Deficiency

## Interventions

- **DEVICE:** Steen Solution™
- **OTHER:** Conventional Lung Transplant

## Key facts

- **NCT ID:** NCT01241942
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-03
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Funding exhausted.
- **Last updated:** 2018-07-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241942, "Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01241942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*